Innoplexus AG
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Sep 2034
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 6, 2026The maintenance fee for System and method of creating index (US 11,669,555) comes due Dec 6, 2026. Unpaid by Jun 7, 2027, it lapses early.
- 2 fees due Apr 3 to 22, 2027 · next Apr 3
- 1 fee due Aug 20, 2027The maintenance fee for System and method for identifying potential targets for pharmaceutical compound (US 11,908,551) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.
- 1 fee due Sep 26, 2027The maintenance fee for System and method of managing access to remote digital platforms (US 11,943,229) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.
- 4 fees due Oct 7 to 21, 2027 · next Oct 7
- 1 fee due Nov 5, 2027The maintenance fee for System and method for interoperability of blockchains (US 10,642,825) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.
Recent changes
- 5 terms have ended since Aug 23, 2026
- Oct 11 US 11,468,070 Method and System for Performing Context-Based Search · lapsed on the fee record
- Sep 6 US 11,436,262 System and Method of Creating Entity Records · lapsed on the fee record
- Aug 30 US 11,429,583 System and Method of Creating Database Arrangement · lapsed on the fee record
- Aug 23 US 11,423,059 System and Method for Restrictive Clustering of Datapoints · lapsed on the fee record
- Aug 23 US 11,419,872 Phosphoinositide 3-Kinase and SRC Inhibitors for Treatment of Pancreatic Cancer · lapsed on the fee record
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D860,238 | Display screen with transitional graphical user interface In force · USPTO record | In force | USPTO record | |
| US D870,129 | Display screen with transitional graphical user interface In force · USPTO record | In force | USPTO record | |
| US D874,481 | Display screen with transitional graphical user interface In force · USPTO record | In force | USPTO record | |
| US D879,819 | Display screen with transitional graphical user interface In force · USPTO record | In force | USPTO record | |
| US D886,125 | Display screen with transitional graphical user interface In force · USPTO record | In force | USPTO record | |
| US D890,199 | Display screen with transitional graphical user interface In force · USPTO record | In force | USPTO record | |
| US D890,791 | Display screen with transitional graphical user interface In force · USPTO record | In force | USPTO record | |
| US D892,849 | Display screen with transitional graphical user interface In force · USPTO record | In force | USPTO record | |
| US D892,850 | Display screen with transitional graphical user interface In force · USPTO record | In force | USPTO record | |
| US 10,452,699 | System and method for executing access transactions of documents related to drug discovery In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 41: 4 patents in force now held by others · 28 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 7 abandoned · 39 no status recorded
Showing 1 to 10 of 48, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/240,697 | Aug 31, 2023 | No status recorded | |
| 18/362,199 | Jul 31, 2023 | No status recorded | |
| 18/219,683 | Jul 9, 2023 | No status recorded | |
| 18/326,209 | May 31, 2023 | No status recorded | |
| 18/308,701 | Method and System for Electronic Decomposition of Data String into Structurally Meaningful Parts | Apr 28, 2023 | Abandoned |
| 18/308,191 | System and Method for Identifying Molecular Pathways Perturbed Under Influence of Drug or Disease | Apr 27, 2023 | Pending |
| 18/175,077 | Feb 27, 2023 | No status recorded | |
| 18/162,830 | Feb 1, 2023 | No status recorded | |
| 18/161,392 | Jan 30, 2023 | No status recorded | |
| 18/161,325 | Jan 30, 2023 | No status recorded |
10 of 48 applications shown.
Pro members see all 48 published applications.